[Gemini: Genesis' irresponsible loans to 3AC eventually led to the company's bankruptcy] Golden Finance reported that Gemini has filed a fraud lawsuit against DCG and Barry Silbert, specifically accusing Genesis of distorting its risk management process and providing huge loans to counterparties including 3AC, in part because these counterparties benefited from GBTC, another subsidiary of DCG. The lawsuit details a total of $2.3 billion in loans to 3AC and shows that the collateral value of the transaction was less than 50% of the total loan amount. Part of this collateral was actually GBTC shares. During this period, 3AC's trading strategy focused on trying to arbitrage the value difference of GBTC by trading NAV premiums. Ultimately, GBTC will trade at a price below net asset value. The lawsuit claims that it was these irresponsible loans to 3AC that ultimately led to Genesis' bankruptcy, and that the motivation for these loans was that it brought benefits to Barry Silbert and DCG. DCG said its $1.1 billion injection into Genesis was to cover up the bankruptcy. The cash injection was a promissory note due in 2032, which on the surface may have improved Genesis' balance sheet, but mainly represented a promise to pay cash in the future. Under generally accepted accounting principles (GAAP), such notes are classified in the "current assets" category, which generally excludes long-term assets of subsidiaries. To hide this misclassification, it was excluded from the average loan maturity in that category.
